The current Global ADHD Market Worth $2.7Bn and is Expected to Reach $3.4Bn by 2015 This is from a new report from Research and Markets on the Global ADHD market, and if you have $12,198 Euros, you can buy it. Innovation is key – manufacturers can no longer expect significant returns on standard extended release […]
See also CADDAC Canadian ADD network meeting in Vancouver part 1, part 2, and part 3 Just got back from the first day of the two day CADDRA (Canadian ADD Resource Alliance’s) ADHD through the lifespan conference here in Vancouver. I’d give you a link to CADDRA but I’m still waiting for them to have a
An extended release version of Focalin has just been approved for treatment of ADHD in adults, adolescents and children by the FDA. It appears the side effects seem to be similar to other stimulant medications for ADD. From a brief look at the pdf on the Focalinxr.com site it looks like you get have the
Cancer and heat disease are numbers 1 and 2. IAN GILLESPIE, from the London Free Press tells us a Canadian Medical Association Journal published a U. of Toronto study that looked at data from 20 hospitals in five provinces involving more than 3,700 patients. * As many as 23,750 patients die each year due to
Medical mistakes third leading cause of deaths in Canada Read More »
Since one of the main tools of dealing with ADD besides coaching, therapy and exercise is ADD medications like Concerta, Strattera, Wellbutrin and Ritalin, ADDers often find themselves in the doctor’s office. Often you only have 10 minutes or less with them so here are some ideas on maximizing that time, especially if you have